In this context, we have recently reported this high tumor selectivity using a CXCR4-targeted fluorescent nanocarrier, that displays the exact self-assembling nanoparticle structure of the nanotoxins, in HNSCC, colorectal cancer [35], and lymphoma [36] models. The gene discussed is CXCR4; the disease is lymphoma.